1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SLAMF6 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA PRDX2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA BLK CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ZNF296 CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA RPRD2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA LTBR CTRPv2 pan-cancer AAC -0.2 3e-06
mRNA CCDC126 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA OR13A1 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA TMEM38A CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA MAPKAPK3 CTRPv2 pan-cancer AAC -0.16 3e-06
Download CSV